[Surgical treatment of pheochromocytoma].


Journal

Problemy endokrinologii
ISSN: 2308-1430
Titre abrégé: Probl Endokrinol (Mosk)
Pays: Russia (Federation)
ID NLM: 0140673

Informations de publication

Date de publication:
11 Nov 2023
Historique:
received: 26 03 2023
accepted: 24 04 2023
revised: 23 04 2023
medline: 17 11 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: epublish

Résumé

This review article contains a summary of modern aspects of preoperative preparation, surgical treatment, and follow-up of patients with adrenal pheochromocytomas. The main component of preoperative preparation is the use of alpha-blockers. The need to prescribe them to all patients is increasingly disputed, especially for patients without severe hypertension. An increasing number of publications demonstrate positive results of treatment without the use of alpha-blockers, advocating an individual approach and the use of the drug according to certain indications. Minimally invasive endoscopic techniques of adrenalectomy have become widespread in surgical treatment. They are represented by laparoscopic and retroperitonescopic technic, including using their single-port modifications. The earliest possible intersection of the central vein in the past was considered the most important aspect of adrenalectomy for pheochromocytoma, currently, due to the development of surgical techniques and anesthesiological manuals, this has ceased to be a mandatory rule of successful surgery. Despite the significant influence of the intersection of this vessel on intraoperative hemodynamics, surgical tactics with its later intersection have their own justifications and do not lead to a deterioration in treatment results. The standard volume of surgical intervention for pheochromocytomas is total adrenalectomy, however, in the presence of hereditary syndromes, such as multiple endocrine neoplasia type 2 syndrome, neurofibomatosis type 1, von Hippel-Lindau syndrome, it is possible to perform cortical-sparing adrenalectomy.

Identifiants

pubmed: 37968950
doi: 10.14341/probl13283
pmc: PMC10680547
doi:

Types de publication

Review English Abstract Journal Article

Langues

rus

Sous-ensembles de citation

IM

Pagination

39-44

Références

J Am Coll Surg. 2011 Apr;212(4):659-65; discussion 665-7
pubmed: 21463807
Surg Endosc. 2009 Feb;23(2):248-54
pubmed: 19037697
Urology. 2013 Sep;82(3):606-11
pubmed: 23859530
Surg Laparosc Endosc Percutan Tech. 2019 Feb;29(1):49-52
pubmed: 30605138
Cancers (Basel). 2022 Aug 09;14(16):
pubmed: 36010839
JAMA Netw Open. 2019 Aug 2;2(8):e198898
pubmed: 31397861
Surg Endosc. 2021 Feb;35(2):728-735
pubmed: 32072283
Br J Surg. 2018 Apr;105(5):544-551
pubmed: 29493779
Br J Surg. 2020 Jan;107(2):e170-e178
pubmed: 31903598
World J Surg Oncol. 2019 Jun 29;17(1):111
pubmed: 31253139
World J Surg. 2010 Jun;34(6):1386-90
pubmed: 20213204
J Hypertens. 2020 Aug;38(8):1443-1456
pubmed: 32412940
Surgery. 2006 Dec;140(6):943-8; discussion 948-50
pubmed: 17188142
Rev Clin Esp (Barc). 2021 Jan;221(1):18-25
pubmed: 33998473
Eur J Endocrinol. 2016 Jan;174(1):R9-18
pubmed: 26297495
Br J Surg. 2018 Jan;105(2):e84-e98
pubmed: 29341163
Hormones (Athens). 2020 Sep;19(3):317-327
pubmed: 32388629
Gland Surg. 2019 Jul;8(Suppl 1):S36-S40
pubmed: 31404183
Surgery. 2011 Sep;150(3):452-8
pubmed: 21878230
Br J Anaesth. 2017 Feb;118(2):182-189
pubmed: 28100521
J Hypertens. 2011 Dec;29(12):2429-32
pubmed: 22025238
Clin Endocrinol (Oxf). 2017 Feb;86(2):163-167
pubmed: 27696513
Int J Surg. 2016 Apr;28 Suppl 1:S118-23
pubmed: 26708860
Eur J Endocrinol. 2022 Mar 18;186(5):D17-D24
pubmed: 35230260
Biomed Pharmacother. 2002;56 Suppl 1:132s-138s
pubmed: 12487269
J Visc Surg. 2021 Jun;158(3):204-210
pubmed: 32773296
Eur J Surg Oncol. 2020 Jun;46(6):991-998
pubmed: 32102743
Clin Endocrinol (Oxf). 2006 Aug;65(2):186-90
pubmed: 16886958
Eur J Endocrinol. 2016 May;174(5):G1-G10
pubmed: 27048283
BJU Int. 2009 Jan;103(2):218-22
pubmed: 18671788
J Urol. 2007 Apr;177(4):1254-7
pubmed: 17382700
J Laparoendosc Adv Surg Tech A. 2019 Dec;29(12):1544-1548
pubmed: 31613691
Surgery. 2003 Dec;134(6):1020-7; discussion 1027-8
pubmed: 14668736
Probl Endokrinol (Mosk). 2021 Nov 15;68(1):8-17
pubmed: 35262293
Acta Anaesthesiol Scand. 2009 Apr;53(4):522-7
pubmed: 19239408
Urology. 2007 May;69(5):849-53
pubmed: 17482920
World J Surg. 2021 Jan;45(1):168-179
pubmed: 32856097
J Surg Res. 2022 Jul;275:87-95
pubmed: 35245831
Ann Surg. 2014 Nov;260(5):740-7; discussion 747-8
pubmed: 25243546
N Engl J Med. 2019 Aug 8;381(6):552-565
pubmed: 31390501
J Clin Endocrinol Metab. 2003 Oct;88(10):4533-9
pubmed: 14557417
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
World J Surg. 2004 Dec;28(12):1323-9
pubmed: 15517476
Surg Endosc. 2022 Oct;36(10):7638-7646
pubmed: 35414133
Wideochir Inne Tech Maloinwazyjne. 2022 Mar;17(1):20-34
pubmed: 35251388
Sisli Etfal Hastan Tip Bul. 2020 Dec 11;54(4):391-398
pubmed: 33364876
Int J Surg. 2019 Jan;61:26-32
pubmed: 30503601

Auteurs

Sh Sh Shikhmagomedov (SS)

Saint Petersburg State University, Clinic of High Medical Technologies named after. N.I. Pirogova.

D V Rebrova (DV)

Saint Petersburg State University, Clinic of High Medical Technologies named after. N.I. Pirogova.

L M Krasnov (LM)

Saint Petersburg State University, Clinic of High Medical Technologies named after. N.I. Pirogova.

E A Fedorov (EA)

Saint Petersburg State University, Clinic of High Medical Technologies named after. N.I. Pirogova.

I K Chinchuk (IK)

Saint Petersburg State University, Clinic of High Medical Technologies named after. N.I. Pirogova.

R A Chernikov (RA)

Saint Petersburg State University, Clinic of High Medical Technologies named after. N.I. Pirogova.

V F Rusakov (VF)

Saint Petersburg State University, Clinic of High Medical Technologies named after. N.I. Pirogova.

I V Slepstov (IV)

Saint Petersburg State University, Clinic of High Medical Technologies named after. N.I. Pirogova.

E A Zgoda (EA)

Saint Petersburg State University, Clinic of High Medical Technologies named after. N.I. Pirogova.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH